Skip to main content
. 2017 Aug 31;7:10180. doi: 10.1038/s41598-017-10465-0

Figure 3.

Figure 3

Dexamethasone enhances anti-GRα binding to the distal IL1RL1 gene promoter in the rs6543115(C)/rs6543116(A) haplotype. (A) Schematic representation of GREs in the IL1RL1 distal and proximal promoters, with the GRE position given in reference to Exon 1a (+1) for the distal promoter and Exon 1b (+1) for the proximal promoter. Boxes indicate the specific GRE sequence in each promoter. (B) ChIP assays for HMC-1 human mast cells stimulated with 100 nM Dex using an Ab57-specific polyclonal antibody against GRα, (C) an antibody against RNA pol II or control normal serum (IgG). The % input represents the % DNA precipitated using the specific antibody. n = 4. Kruskal-Wallis test with Dunn’s multiple comparison post-test. **p < 0.01; ***p < 0.001. (D) Luciferase activity associated with a 1211-bp region corresponding to the IL1RL1 distal promoter containing the three putative GREs (GREs 1, 2 and 3) in haplotypes rs6543115(C)/rs6543116(A) (pIL1RL1(Hap1)-Luc) or rs6543115(G)/rs6543116 (G) (pIL1RL1(Hap2)-Luc, as determined in A549 cells treated with 0–1000 nM Dex. (E) Schematic luciferase reporter plasmids generated from pIL1RL1(Hap1)-Luc and percentage of luciferase activity induced by 100 nM Dex. Luciferase activity was normalised to Renilla (F/R = firefly/Renilla activity) and related to the control. Error bars represent the means ± SEM of 3 experiments. Two-way ANOVA. **p < 0.01; ***p < 0.001.